Normalizing BP in Elderly With Prior CV Event History May Increase Mortality
Normalized blood pressure is associated with an increased risk for all-cause mortality for older adults during hypertension treatment.
Hypertension
Lower SBP Linked to Cognitive Decline in Older Adults Taking Antihypertensives
Elderly individuals treated with antihypertensive medications and have a SBP of ≥130 mm Hg display less cognitive decline after 1 year compared with individuals with an SBP of <130 mm Hg.
FDA Provides List of Nitrosamine-Free ARB Medications
The FDA has released a list of 40 ARBs that do not contain any known nitrosamine impurities.
Coronary Artery Calcium Score Reliably Risk Stratifies Adults With Hypertension
Coronary artery calcium scoring can risk-stratify patients with hypertension, including those who are SPRINT eligible and can recategorize risk around the atherosclerotic CVD 10% threshold.
Catheter-Based Renal Sympathetic Denervation Effectively Lowers BP
Renal sympathetic denervation significantly reduced blood pressure compared with shame procedures.
Endovascular Renal Denervation Results in Sustained BP Reduction
The benefits of reduced blood pressure following renal denervation surgery are maintained for at least six months.
Does Ranolazine Potentiate the Effects of ACE Inhibitors, Angiotensin Receptor Blockers?
Ranolazine potentiates the effects associated with ACE inhibitors, as well as angiotensin receptor blockers.
Clinical Outcomes Compared With Generics, Brand-Name Drugs for Chronic Conditions
An analysis found comparable clinical outcomes among patients who initiated generics vs those who were treated with brand-name drugs for chronic conditions.
FDA Approves New Valsartan Product Following Major Recall
The FDA has approved a new generic version of Diovan (Novartis) that does not contain NDMA or NDEA, 2 potentially carcinogenic impurities identified in several recalled valsartan products.
Prenatal Docosahexaenoic Acid Exposure May Decrease Risk for Obesity-Associated Elevated BP
Docosahexaenoic acid supplements given to mothers during pregnancy may lower systolic and diastolic blood pressure associated with overweight and obesity in their children.
Next post in Hypertension
